MedTrace Logo

Feasibility, Acceptability, and Effectiveness of a Hatha Yoga-in Patients Hospitalized for Schizophrenia

NCT07454200 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-03-06

No results posted yet for this study

Summary

The current study aims to examine the feasibility, acceptability, and preliminary effectiveness of a Hatha yoga-based group intervention on reminiscence functions and mindfulness in a sample of patients hospitalized for schizophrenia.

Conditions

  • SCHIZOPHRENIA 1 (Disorder)
  • Hospitalized Adult Patients

Interventions

BEHAVIORAL

Intervention Arm: Hatha Yoga

Hatha Yoga balances the body's "sun" (ha) and "moon" (tha) energies to promote physical, mental, and emotional wellness. There will be eight two-hour Hatha yoga-based group therapy sessions over eight weeks. A professional yoga teacher and mental health nurse will lead these helpful sessions. Better memory and alertness are the major goals. To ensure participant safety and study validity, a multidisciplinary team assesses health, trauma triggers, and personal goals before the program begins. The lessons are held in a comfortable area with adjustable props and lighting. Trainers employ trauma-sensitive language and retain privacy on all participants, including "Hesitant" and "Overwhelmed." Each session includes grounding, pranayama, asana, and dhyana.

Sponsors & Collaborators

  • The Hashemite University

    lead OTHER

Principal Investigators

  • Abdallah Abu Khait, Ph.D.,MSN · The Hashemite University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-11-30
Completion
2027-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07454200 on ClinicalTrials.gov